1. Altekruse SF, Kosary CL, Krapcho M, et al., eds. SEER cancer statistics review, 1975–2007. Bethesda, MD: National Cancer Institute; 2010. Based on November 2009 SEER data submission. Available at
http://seer.cancer.gov/csr/1975_2007
. Accessed November 19, 2012.
2. Bevers TB, Anderson BO, Bonaccio E, et al. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw 2009;7(10):1060–1096.
3. Curtis RE, Ron E, Hankey BF, Hoover RN. New malignancies following breast cancer. In: Curtis RE, Freedman DM, Ron E, et al., eds. New Malignancies among Cancer Survivors: SEER Cancer Registries, 1973–2000. Bethesda, MD: National Cancer Institute; 2006.
4. Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer 2004;101(8):1712–1719.
5. Fisher B, Costantino JP, Redmond CK, et al. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994;86(7):527–537.